Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment

Journal of Neurology

Volumn 254, Issue 8, 2007, Pages 1000-1008

  Caroli, Anna ^a   Testa, Cristina ^a,b   Geroldi, Cristina ^a   Nobili, Flavio ^c   Guerra, Ugo P ^d   Bonetti, Matteo ^e   Frisoni, Giovanni B ^a  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d OSPEDALI RIUNITI   (Italy)

^e Istituto Clinico Citta di Brescia   (Italy)

Author keywords

Medial temporal atrophy; Mild cognitive impairment; SPECT; White matter

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M;

ADULT; AGED; ARTICLE; ATROPHY; BRAIN PERFUSION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RATING SCALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; TEMPORAL LOBE ATROPHY; WHITE MATTER;

AGE FACTORS; AGED; ANALYSIS OF VARIANCE; ATROPHY; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROGLIA; NEUROPSYCHOLOGICAL TESTS; STATISTICS AS TOPIC; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34548410918     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0498-z     Document Type: Article

References (49)

1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303-308
2. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58:397-405
3. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58:1985-1992
4. Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E (1999) Prediction of AD with MRIbased hippocampal volume in mild cognitive impairment. Neurology 52:1397-1403
5. De Carli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D (2001) Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 58:643-647
6. De Groot K, Schmidt DK, Arlt AC, Gross WL, ReinHold-Keller E (2001) Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol 58:1215-1221
7. 123I]Iodoamphetamine SPECT in mild cognitive impairment: implications for a novel predictor of Alzheimer's disease. Am J Psychiatry 159:474-476
8. Small AS (2005) Alzheimer disease, in living color. Nat Neurosci 8:404-405
9. Garrido GE, Furuie SS, Buchpiguel CA, Bottino CM, Almeida OP, Cid CG, Camargo CH, Catro CC, Glabus MF, Busatto GF (2002) Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT study. J Neurol Neurosurg Psychiatry 73:508-516
10. Waldemar G, Christiansen P, Larsson HB, Hogh P, Laursen H, Lassen NA, Paulson OB (1994) White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates. J Neurol Neurosurg Psychiatry 57:1458-1465
11. Ott BR, Faberman RS, Noto RB, Rogg JM, Hough TJ, Tung GA, Spencer TK (1997) A SPECT imaging study of MRI white matter hyperintensity in patients with degenerative dementia. Dement Geriatr Cogn Disord 8:348-354
12. Ebmeier KP, Prentice N, Ryman A, Halloran E, Rimmington JE, Best JK, Goodwin GM (1997) Temporal lobe abnormalities in dementia and depression: a study using high resolution single photon emission tomography and magnetic resonance imaging. J Neurol Neurosurg Psychiatry 63:597-604
13. Shulman KI (2000) Clock-drawing: is it the ideal cognitive screening test?. Int J Geriatr Psychiatry 15:548-561
14. Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E (1996): Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci 17:305-309
15. Basso A, Capitani E, Laiacona M (1987) Raven's coloured progressive matrices: normative values on 305 adult normal controls. Funct Neurol 2:189-194
16. Spinnler H, Tognoni G (1987) Standardizzazione e taratura italiana di test neurologici. Ital J Neurol Sci 8(suppl):47-50
17. Novelli G, Papagno C, Capitani E, Laiacona M, Cappa SF, Vallar G (1986) Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Arch Psicol Neurol Psichiatr 47:477-506
18. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A (2002) Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci 22:443-447
19. Radloff LS (1977) The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Measure 1:385-401
20. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P, European Task Force of Age Related White Matter Changes (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32:1318-1322
21. Rossi R, Boccardi M, Sabattoli F, Galluzzi S, Alaimo G, Testa C, Frisoni GB (2006) Topographic correspondence between white matter hyperintensities and brain atrophy. J Neurol 253:919-927
22. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J (1992) Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55:967-972
23. Bresciani L, Rossi R, Testa C, Geroldi C, Galluzzi S, Laakso MP, Beltramello A, Soininen H, Frisoni GB (2005) Visual assessment of medial temporal atrophy on MR films in Alzheimer's disease: comparison with volumetry. Aging Clin Exp Res 17:8-13
24. Chang LT (1978) A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 25:638-643
25. Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT (2003) Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 20:1309-1319
26. SPM, Statistical Parametric Mapping, version 2 (2002). London: Functional Imaging Laboratory. Available at: http://www.fil.ion.ucl.ac.uk/spm/software/ spm2
27. Rorden C, Brett M (2000) Stereotaxic display of brain lesions. Behav Neurol 12:191-200
28. Barnden LR, Behin-Ain S (2004) Data Based Optimization of Brain SPECT Processing for Voxel-based Statistical Analysis. NSS-MIC Conference Record
29. Barnden LR, Behin-Ain S, Kwiatek R, Casse R, Yelland L (2005) Age related preservation and loss in optimized brain SPECT. Nucl Med Commun 26:497-503
30. Frisoni GB, Testa C, Sabattoli F, Beltramello A, Soininen H, Laakso MP (2005) Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study. J Neurol Neurosurg Psychiatry 76:112-114
31. Filippini N, Scassellati C, Boccardi M, Pievani M, Testa C, Bocchio-Chiavetto L, Frisoni GB, Pennarelli M (2006) Influence of serotonin receptor 2A His452Tyr polymorphism on brain temporal structures: a volumetric MR study. Eur J Hum Genet 14:443-449
32. Yamaguchi S, Meguro K, Itoh M, Hayasaka C, Shimada M, Yamazaki H, Yamadori A (1997) Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET. J Neurol Neurosurg Psychiatry 62:596-600
33. Mosconi L, Tsui WH, De Santi S, Li J, Rusinek H, Convit A, Li Y, Boppana M, de Leon MJ (2005) Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 64:1860-1867
34. Matsuda H, Kitayama N, Ohnishi T, Asada T, Nakano S, Sakamoto S, Imabayashi E, Katoh A (2002) Longitudinal evaluation of both morphological and functional changes in the same individuals with Alzheimer's disease. J Nucl Med 43:304-311
35. Sjobeck M, Englund E (2001) Alzheimer's disease and the cerebellum: a morphological study on neuronal and glial changes. Dement Geriatr Cogn Disord 12:211-218
36. Newberg A, Cotter A, Udeshi M, Brinkman F, Glosser G, Alavi A, Clark C (2003) Brain metabolism in the cerebellum and visual cortex correlates with neuropsychological testing in patients with Alzheimer's disease. Nucl Med Commun 24:785-790
37. Gootjes L, Teipel SJ, Zebuhr Y, Schwarz R, Leinsinger G, Scheltens P, Moller HJ, Hampel H (2004) Regional Distribution of White Matter Hyperintensities in Vascular Dementia, Alzheimer's Disease and Healthy Aging. Dement Geriatr Cogn Disord 18:180-188
38. Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, Weiner MV, Chui HC, Jagust WJ (2004) White matter lesions impair frontal lobe function regardless of their location. Neurology 63:246-253
39. Wen W, Sachdev P, Shnier R, Brodaty H (2004) Effect of white matter hyperintensities on cortical cerebral blood volume using perfusion MRI. Neuroimage 21:1350-1356
40. Augustine JR (1996) Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res Brain Res Rev 22:229-244
41. Augustine JR (1985) The insular lobe in primates including humans. Neurol Res 7:2-10
42. Yang DW, Kim BS, Park JK, Kim SY, Kim EN, Sohn HS (2002) Analysis of cerebral blood flow of subcortical vascular dementia with single photon emission computed tomography: adaptation of statistical parametric mapping. J Neurol Sci 203(204):199-205
43. Benoit M, Koulibaly PM, Migneco O, Darcourt J, Pringuey DJ, Robert DH (2002) Brain perfusion in Alzheimer's disease with and without apathy: a SPECT study with statistical parametric mapping analysis. Psychiatry Res 114:103-111
44. Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M, Kunihiro T, Nakano S, Takasaki M (2000) Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 41:1155-1162
45. Van Laere K, Versijpt J, Audenaert K, Koole M, Goethals I, Achten E, Dierckx R (2001) 99mTc-ECD brain perfusion SPET: variability, asymmetry and effects of age and gender in healthy adults. Eur J Nucl Med 28:873-887
46. Kemp PM, Holmes C, Hoffmann SM, Bolt L, Holmes R, Rowden J, Fleming JS (2003) Alzheimer's disease: differences in technetium)99m HMPAO SPECT scan findings between early onset and late onset dementia. J Neurol Neurosurg Psychiatry 74:715-719
47. Soonawala D, Amin T, Ebmeier KP, Steele JD, Dougall NJ, Best J, Migneco O, Nobili F, Scheidhauer K (2002) Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake. Neuroimage 17:1193-1202
48. Lee YC, Liu RS, Liao YC, Sun CM, Wang PS, Wang PN, Liu HC (2003) Statistical parametric mapping of brain SPECT perfusion abnormalities in patients with Alzheimer's disease. Eur Neurol 49:142-145
49. Kapeller P, Barber R, Vermeulen RJ, Ader H, Scheltens P, Freidl W, Almkvist O, Moretti M, del Ser T, Vaghfeldt P, Enzinger C, Barkhof F, Inzitari D, Erkinjunti T, Schmidt R, Fazekas F, European Task Force of Age Related White Matter Changes (2003) Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke 34:441-445